Ignite Creation Date:
2024-05-05 @ 5:16 PM
Last Modification Date:
2024-10-26 @ 9:30 AM
Study NCT ID:
NCT00420953
Status:
COMPLETED
Last Update Posted:
2017-09-08
First Post:
2007-01-08
Brief Title:
Relative Bioavailability of PM101 IV and Cordarone IV
Sponsor:
Prism Pharmaceuticals
Organization:
Baxter Healthcare Corporation
Study Overview
Official Title:
A Randomized Double-blind 2-period Crossover Trial to Determine the Relative Bioavailability of PM101 IV Amiodarone HCl and Cordarone IV in Healthy Adult Volunteers
Status:
COMPLETED
Status Verified Date:
2017-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Determine the relative bioavailability of PM101 IV and Cordarone IV
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None